Establishing a category defining clinical data solution to fuel innovation, enhance patient care, and improve operational efficiencies in healthcare
NORRISTOWN, Pa., June 12, 2025 -- MRO Corp. (MRO), the leading clinical data exchange company in healthcare, announced today the acquisition of Q-Centrix Corp. (Q-Centrix), a leading enterprise clinical data management platform, enabling hospitals and health systems to turn fragmented clinical data into actionable information. This strategic combination positions MRO to further accelerate the exchange of clinical data throughout the healthcare ecosystem for providers, payers, life sciences and users of clinical data. The combined company services over 2,000 hospitals and health systems, more than 7,000 clinics, and nearly 250 payers. The financial terms of the transaction were not disclosed.
"At MRO, we believe there is tremendous untapped value in unlocking and leveraging clinical data that resides in fragmented, siloed systems today," said Jason Brown, CEO of MRO. "Combining MRO's leading clinical data exchange solutions and Q-Centrix's clinical data management capabilities creates a category defining, fit for purpose platform, enabling high fidelity, low latency acquisition, abstraction, curation, and exchange of clinical data to power better patient care and reduce costs across the healthcare ecosystem."
With a comprehensive clinical data management platform, providers, payers, and life sciences will be able to simplify complexity, accelerate decisions, and advance outcomes. By transforming clinical data from raw records into enriched, curated data assets, MRO and Q-Centrix create scalable value that supports more precise decision-making and broader clinical applications.
"MRO and Q-Centrix share a commitment to advancing the industry in service of our customers," said Milton Silva-Craig, CEO at Q-Centrix. "That focus is fueling the creation of a first-of-its-kind platform—seamlessly integrating systems and delivering structured, highly valuable data sets to support clinical care, operational performance, breakthrough research, and regulatory compliance. Purpose-built around our customers' most pressing needs, this is innovation where it matters most."
The acquisition is supported by several leading healthcare technology investors, including Parthenon Capital, a growth-oriented private equity firm and an existing investor in MRO. As part of the transaction, Parthenon Capital made a significant new investment to support MRO's growth over time. MRO is acquiring Q-Centrix from TPG Growth, the middle market and growth equity platform of global alternative asset management firm TPG.
About MRO
MRO is accelerating the exchange of clinical data throughout the healthcare ecosystem on behalf of providers, payers, and users of clinical data. By utilizing industry-leading solutions and incorporating the latest technology, MRO facilitates the efficient management and exchange of clinical data for all stakeholders. With a 23-year legacy, MRO brings a technology-driven mindset built upon a client-first service foundation and a relentless focus on client excellence. For more information on how MRO is empowering healthcare organizations of every type and scale with proven, enterprise-wide clinical data solutions, visit www.mrocorp.com.
About Q-Centrix
Q-Centrix sees clinical data differently—as curated data sets with infinite possibilities. As the pioneer of the industry's first Enterprise Clinical Data Management (eCDM™) platform, Q-Centrix integrates proprietary technology, the largest and most diverse team of clinical data experts, data, and insights derived from 1,200 healthcare partners to improve patient outcomes, enhance performance, support strategic growth, and boost operational efficiency. From baseline data sets for health systems' clinical data management needs, to fit-for-purpose data sets designed for clinical research, Q-Centrix provides unparalleled versatility to meet an evolving clinical data landscape.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
